Tuesday, February 5, 2019

Pharma Reviews: Sugar stocks to do well for next 2-3 quarters: Dipan Mehta

Given the pharmaceutical industry scenario, we have been generally very underweight in the entire pharma pack be it Lupin, Sun Pharma or Cipla, ...
Read more: Sugar stocks to do well for next 2-3 quarters: Dipan Mehta